Ferroptosis: challenges and opportunities for nanomaterials in cancer therapy

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cancer Biology

Background:

• Ferroptosis is a regulated cell death mechanism driven by oxidative damage, showing significant anti-cancer potential.
• Current small-molecule ferroptosis inducers exhibit limitations including poor solubility, drug resistance, and low targeting efficiency, hindering clinical translation.
• Nanotechnology offers innovative solutions for ferroptosis-driven cancer therapy, particularly through stimuli-responsive nanomaterials.

Purpose of the Study:

• To review the physiological features of ferroptosis and its challenges in cancer therapy.
• To summarize the application of stimuli-responsive nanomaterials in inducing ferroptosis.
• To provide future perspectives for the development of intelligent nano-ferroptosis inducers.

Main Methods:

• Literature review and synthesis of existing research on ferroptosis and nanomaterials.
• Classification of ferroptosis-inducing nanomaterials based on external and internal stimuli.
• Analysis of the advantages and limitations of current approaches.

Main Results:

• Ferroptosis is characterized by iron accumulation and lipid peroxidation.
• Stimuli-responsive nanomaterials offer spatiotemporal control for targeted ferroptosis induction.
• Nanomaterials can be designed to respond to various internal and external triggers for enhanced therapeutic efficacy.

Conclusions:

• Stimuli-responsive nanomaterials are a promising strategy to overcome the limitations of traditional ferroptosis inducers.
• Further research into intelligent nano-ferroptosis inducers is crucial for advancing cancer therapy.
• This review provides a framework for designing next-generation ferroptosis-based cancer treatments.